Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
specificStage II includes: IIA: (T2, N0, M0, G3); (T2, N0, M0, GX); IIB: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T2: Tumor invades the muscularis propria. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)
18
Centers
14
Active Trials
—
Cancer Funding
Top Centers for Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8(18)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 74.0 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 57.8 |
| 3 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 57.8 |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 57.8 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 57.8 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 57.8 |
| 7 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 57.8 |
| 8 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 57.8 |
| 9 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 57.8 |
| 10 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 57.8 |
| 11 | Cancer Center at IllinoisUrbana, IL Active Research Program | 57.8 |
| 12 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 57.8 |
| 13 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 57.8 |
| 14 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | 36.5 |
| 15 | NCI Comprehensive | 36.5 |
| 16 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | 36.5 |
| 17 | 36.5 | |
| 18 | Louisiana Cancer Research CenterNew Orleans, LA | 36.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →